Little information is available about the correlation between viral ribonucleic acid (RNA) load in plasma and biological responses to COVID-19 infection. Wide variations in the severity of COVID-19 infections have intensified the effort to better understand viral load dynamics as it relates to infectious disease. Effective and reliable analytical techniques are needed to produce fast, efficient and reproducible results.
Download this whitepaper to discover how next-generation ELISA technology can:
Accelerate biomarker discovery and quantification
Provide in-depth analysis of COVID-19 host cytokine levels
Deliver high quality, reproducible immunoassay data
